News Daily News Revascularization Decisions in the Elderly Require a Holistic Approach: AHA Caitlin E. Cox November 24, 2025
News Daily News Long-Awaited CREST-2 Results Bolster Stents for Asymptomatic Carotid Stenosis Todd Neale November 21, 2025
News Conference News AHA 2025 Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight Caitlin E. Cox November 18, 2025
News Conference News AHA 2025 Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR Caitlin E. Cox November 14, 2025
News Conference News AHA 2025 Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia Michael O'Riordan November 14, 2025
News Conference News AHA 2025 Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD Todd Neale November 13, 2025
News Conference News AHA 2025 DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation Todd Neale November 12, 2025
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News TCT 2025 PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats Todd Neale October 28, 2025
Presentation TCT 2025 TCT 487: Percutaneous Coronary Intervention with Drug-Coated Balloons in de novo Lesions in Patients with Diabetes Mellitus: A Real-World Experience Presenter: Victor Alfonso Jimenez Diaz October 28, 2025
Presentation TCT 2025 Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial Presenter: Upendra Kaul October 28, 2025
Presentation TCT 2025 TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention Presenter: Ahmed A. Mahmoud October 28, 2025
Presentation TCT 2025 TCT 496: Type 2 Diabetes Is Linked to More Severe Coronary Artery Disease on Cardiac Computed Tomography Angiography but Not to More Invasive Treatment: Insights from a Propensity-Matched Study Presenter: WIllem Robert van de Vijver October 28, 2025
Presentation TCT 2025 TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis Presenter: Mehmet Cilingiroglu October 28, 2025
Presentation TCT 2025 TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis Presenter: Dawood Shehzad October 28, 2025
Presentation TCT 2025 TCT 497: Combined Assessment of Lipoprotein(a) and Non-Culprit Coronary LesionSeverity on Clinical Outcomes in Acute Coronary Syndrome Presenter: Hirokazu Tanaka October 28, 2025